- Home
- PBBK vs APLT Comparison
PBBK vs APLT Comparison
Compare PBBK & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBBK
- APLT
- Stock Information
- Founded
- PBBK 1919
- APLT 2016
- Country
- PBBK United States
- APLT United States
- Employees
- PBBK N/A
- APLT N/A
- Industry
- PBBK Banks
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- PBBK Finance
- APLT Health Care
- Exchange
- PBBK Nasdaq
- APLT Nasdaq
- Market Cap
- PBBK 45.2M
- APLT 42.5M
- IPO Year
- PBBK N/A
- APLT 2019
- Fundamental
- Price
- PBBK $18.02
- APLT $0.33
- Analyst Decision
- PBBK
- APLT Buy
- Analyst Count
- PBBK 0
- APLT 7
- Target Price
- PBBK N/A
- APLT $6.10
- AVG Volume (30 Days)
- PBBK 4.6K
- APLT 2.1M
- Earning Date
- PBBK 08-13-2025
- APLT 08-06-2025
- Dividend Yield
- PBBK N/A
- APLT N/A
- EPS Growth
- PBBK 12.16
- APLT N/A
- EPS
- PBBK 0.83
- APLT N/A
- Revenue
- PBBK $12,804,000.00
- APLT $265,000.00
- Revenue This Year
- PBBK N/A
- APLT $1,768.13
- Revenue Next Year
- PBBK N/A
- APLT $292.85
- P/E Ratio
- PBBK $22.57
- APLT N/A
- Revenue Growth
- PBBK 5.21
- APLT N/A
- 52 Week Low
- PBBK $13.85
- APLT $0.30
- 52 Week High
- PBBK $19.05
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- PBBK 66.45
- APLT 42.58
- Support Level
- PBBK $16.49
- APLT $0.30
- Resistance Level
- PBBK $19.05
- APLT $0.39
- Average True Range (ATR)
- PBBK 0.59
- APLT 0.03
- MACD
- PBBK 0.14
- APLT 0.00
- Stochastic Oscillator
- PBBK 91.23
- APLT 21.64
About PBBK PB Bankshares Inc.
PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.